# NHS National Pharmaceuticals - Everolimus and terminated agreement products

> Tender notice from UK public-sector procurement sources.

## Key facts

- Public buyer: [NHS England](/buyers/nhs-england/contract-awards)
- Tender value: £7,403,286
- Published: 9 April 2021
- Planned start: 15 May 2021
- Planned end: 1 March 2022
- Stage: open_tender
- Procurement category: goods
- Notice ID: b7aad1a9-5aca-40f3-a4d7-5c1e65f5be1b-427538
- OCID: ocds-b5fd17-a87524a8-9992-4a36-99de-0d633112b605

## Description

Tender Close: 26th April, 13:00\. Invitation to offer for NHS National Pharmaceuticals - Everolimus and terminated agreement products Offer reference number: CM/PHG/21/5632 Period of framework agreement: Start date to be confirmed with an option or options to extend \(at the Authority's discretion\) for a period or periods up to a total of 24 months\. Potential periods of call-offs under the framework agreement: Everolimus: All regions: to commence as soon as possible with an end date of 01/03/2022 Oral Products: All regions: to commence as soon as possible with an end date of 28/02/2022 Hospital Only Products: DLS, DNE, DNW, DLN and DSW regions: to commence as soon as possible with an end date 31/01/2022

## Related contract awards

- [Transformation Delivery Services - Establishing Operational Excellence \(EOE\)](/contracts/ocds-b5fd17-b08595d2-8961-409b-9b62-7b01d7a64541): NHS England
- [Identity Access Management - Service Adoption and Enablement](/contracts/ocds-b5fd17-08ebad6c-84fb-4e62-9afd-d06d220dd3a5): NHS England
- [OutSystems licenses for MAPPTI \(AP&P\)](/contracts/ocds-b5fd17-521fbf90-6e93-4366-b3bc-47aa2efd447d): NHS England

## Source

[View the original notice on Contracts Finder](https://www.contractsfinder.service.gov.uk/Notice/b7aad1a9-5aca-40f3-a4d7-5c1e65f5be1b-427538)